HOME >> MEDICINE >> NEWS
Report 13 in RERF study of mortality of A-bomb survivors extends coverage through 1997

Report 13 in an ongoing series of reports from the Radiation Effects Research Foundation (RERF) on mortality in the Life Span Study (LSS) cohort of A-bomb survivors addresses solid cancer and noncancer disease mortality for the years 1950-1997.

Authored by Dale Preston and his colleagues Yukiko Shimizu, Donald A. Pierce, Akihiko Suyama and Kiyohiko Mabuchi, the study appears in the October issue of Radiation Research.

The authors found that while excess rates for radiation-related cancers have increased throughout the study period, relative risks have declined with increasing attained age. As noted in previous reports, the relative risks are highest for those exposed as children.

No significant difference between cities (Hiroshima and Nagasaki) has been found for either the relative or absolute excess solid cancer risk.

Evidence for radiation effects on noncancer mortality continues to be strong, with statistically significant increases for heart disease, digestive diseases, and respiratory diseases.

The cohort studied consists of over 86,000 people with individual dose estimates, with 60% having doses of at least 5 mSv.


'"/>

Contact: Dale L. Preston
preston@rerf.or.jp
Radiation Research Society
20-Oct-2003


Page: 1

Related medicine news :

1. National Academies advisory: Report assesses health implications of perchlorate exposure
2. Report on health insurance coverage of Iowa children shows gaps
3. Report finds new model of care can improve quality, lower costs and increase physician efficiency
4. Michelle Trudeau wins 2004 Victor Cohn Prize for Excellence in Medical Reporting
5. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
6. Latest Public Policy & Aging Report forecasts possible US labor shortage
7. Report finds inactivated influenza virus vaccines effective in children
8. Microneedles: Report describes progress in new technology for painless drug delivery
9. Report gives NIH-sponsored clinical research a good report card
10. Report cites risks associated with over-the-counter cosmetic contact lenses
11. Report shows high arsenic in some southeast NH private wells

Post Your Comments:
(Date:4/25/2015)... Providenciales, Turks and Caicos Islands, BWI (PRWEB) April 25, ... Providenciales International Airport (PLS) has celebrated three months of ... since reopening on January 5, 2015. , As ... phases, the interior of Providenciales airport was completely redesigned ... area has quickened up the process of getting out ...
(Date:4/25/2015)... April 25, 2015 On Friday, April ... RFID Journal’s annual Best Implementation Award. This award ... the best use of RFID technology to improve its ... the company that best demonstrates how RFID is delivering ... at RFID Journal Live! 2015 in San Diego, the ...
(Date:4/24/2015)... AK (PRWEB) April 24, 2015 As ... (#MOTMC2015) and the unique sacrifices of these young men ... for Service members, Veterans and their Families” presents a ... training is designed to gain a better understanding of ... health and wellness. For those – civilian and military ...
(Date:4/24/2015)... The 1975 have had an intense ... globe to theaters, festivals and TV performances. Now that they’ve ... their label, Dirty Hit Records, to provide clean drinking water ... launched Cadence & Cause website, this four-piece has ... and a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term ... their exclusive agreement with LTC Solutions for All LLC ... partner. , Anchor has more than 18 years of ... associations, and is currently the designated advocate for the ... Insurance member benefit. , “I am very pleased to ...
Breaking Medicine News(10 mins):Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... 2015 Hospira, Inc. (NYSE: ... biosimilar therapies, spoke about the importance of extrapolation in ... Association (EGA) annual European Biosimilars Group conference in ... announced the publication of a pivotal white paper titled, ... promise of biosimilars." Speaking at the ...
(Date:4/24/2015)... April 24, 2015  Blueprint Medicines today announced ... and potent inhibitor of fibroblast growth factor receptor ... of hepatocellular carcinoma (HCC) that are dependent on ... induced complete tumor regression in a subset of ... at the highest dose levels. These data will ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3
Cached News: